ARTICLE | Company News
Artemis, Merck deal
November 1, 2004 8:00 AM UTC
Artemis will construct RNAi-modified genetically engineered mice that MRK can use for in vivo functional analysis of disease-related genes. Artemis will use its ArteMice platform to generate knock-dow...